But experts warn that these medications have yet to prove effective in treating COVID-19 patients.
A number of separate clinical trials of these medications and others are underway in several countries, including the U.S.
A preprint study in China also claimed to show that hydroxychloroquine benefitted COVID-19 patients, but it had significant methodology problems, Keshtkar-Jahromi says.
Convalescent PlasmaAnother treatment approach involves injecting COVID-19 patients with blood plasma from people who have recovered from the illness.
But some answers can be expected in the next few weeks and months as the results of clinical trials emerge.